APIs : Symbiotec enjoys a strong global leadership position in corticosteroid and steroidal hormone APIs, with a global volume market share of 38.2% and 23.8%, respectively. Its portfolio comprises of ~60 products across sterile and non-sterile formats, catering to a diversified customer base of 200+ clients across 40+ countries, including 150+ export customers. Strong customer stickiness is reflected in an average relationship tenure of nearly 10 years with its top 10 customers. The corticosteroid and steroidal hormone APIs segment is expected to grow at ~810% CAGR during FY26FY29E to be driven by a stable base business growth and traction from new...